The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma.

Progress in human tumour immunology and immunotherapy

2001 • 1,327 citations

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1997 • 1,235 citations

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

2002 • 851 citations

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.

1994 • 771 citations

Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes

1998 • 728 citations

A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens

1998 • 712 citations

CONTRIBUTION TO THE KNOWLEDGE OF SARCOMA

1891 • 656 citations

BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes

1995 • 598 citations

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.

1995 • 591 citations

Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses

2000 • 407 citations

DNA methylation and cancer

2002 • 319 citations

Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library

1998 • 307 citations

Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens

1998 • 281 citations

LAGE-1, a new gene with tumor specificity

1998 • 268 citations

SSX: A multigene family with several members transcribed in normal testis and human cancer

1997 • 242 citations

Increasing Tumor Antigen Expression Overcomes “Ignorance” to Solid Tumors via Crosspresentation by Bone Marrow-Derived Stromal Cells

2002 • 239 citations

A Breast and Melanoma-Shared Tumor Antigen: T Cell Responses to Antigenic Peptides Translated from Different Open Reading Frames

1998 • 208 citations

Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen ny-eso-1 but not mage-a1 or ct7

2001 • 197 citations

Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients.

2000 • 192 citations

Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials

1995 • 146 citations

Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity.

2001 • 134 citations

HLA class I antigen loss, tumor immune escape and immune selection

2002 • 127 citations

Proteasome-Assisted Identification of a SSX-2-Derived Epitope Recognized by Tumor-Reactive CTL Infiltrating Metastatic Melanoma

2002 • 127 citations

CT10: A new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis

2000 • 124 citations

Immunomic analysis of human sarcoma

2003 • 113 citations

Interleukin-2-induced, melanoma-specific T cells recognize camel, an unexpected translation product ofLAGE-1

1999 • 103 citations

Efficient Simultaneous Presentation of NY-ESO-1/LAGE-1 Primary and Nonprimary Open Reading Frame-Derived CTL Epitopes in Melanoma

2000 • 86 citations

cDNA and protein characterization of humanMAGE-10

1999 • 48 citations

Soft tissue sarcoma as a model disease to examine cancer immunotherapy

2001 • 28 citations

Immunotherapeutic approaches to sarcoma

1999 • 21 citations

Toward a New Human Species?

2002 • 7 citations